108 related articles for article (PubMed ID: 1472924)
1. Beta 2 microglobulin level as an indicator of prognosis in diffuse large cell lymphoma.
Avilés A; Zepeda G; Díaz-Maqueo JC; Rodriguez L; Guzmán R; García EL; Talavera A
Leuk Lymphoma; 1992 May; 7(1-2):135-8. PubMed ID: 1472924
[TBL] [Abstract][Full Text] [Related]
2. Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase.
Suki S; Swan F; Tucker S; Fritsche HA; Redman JR; Rodriguez MA; McLaughlin P; Romaguera J; Hagemeister FB; Velasquez WS
Leuk Lymphoma; 1995 Jun; 18(1-2):87-92. PubMed ID: 8580834
[TBL] [Abstract][Full Text] [Related]
3. Value of serum beta 2 microglobulin as an indicator of early relapse in diffuse large cell lymphoma.
Avilés A; Narváez BR; Díaz-Maqueo JC; Guzmán R; Talavera A; García EL
Leuk Lymphoma; 1993 Mar; 9(4-5):377-80. PubMed ID: 7688627
[TBL] [Abstract][Full Text] [Related]
4. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
Rodriguez J; Pugh WC; Romaguera JE; Luthra R; Hagemeister FB; McLaughlin P; Rodriguez MA; Swan F; Cabanillas F
Ann Oncol; 1994 Nov; 5(9):847-9. PubMed ID: 7848887
[TBL] [Abstract][Full Text] [Related]
5. Significance of tumor burden, vascular endothelial growth factor, lactate dehydrogenase and beta-2 microglobulin serum levels in advanced diffuse large B cell lymphoma.
Milanovic N; Matkovic S; Ristic D; Jelic S; Petrovic M
J BUON; 2012; 17(3):497-501. PubMed ID: 23033288
[TBL] [Abstract][Full Text] [Related]
6. Prognostic models for diffuse large B-cell lymphoma.
Conconi A; Zucca E; Roggero E; Bertoni F; Bernasconi A; Mingrone W; Pedrinis E; Cavalli F
Hematol Oncol; 2000 Jun; 18(2):61-73. PubMed ID: 10960876
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of serum beta-2 microglobulin in patients with diffuse large B-cell lymphoma in the rituximab era.
Seo S; Hong JY; Yoon S; Yoo C; Park JH; Lee JB; Park CS; Huh J; Lee Y; Kim KW; Ryu JS; Kim SJ; Kim WS; Yoon DH; Suh C
Oncotarget; 2016 Nov; 7(47):76934-76943. PubMed ID: 27764777
[TBL] [Abstract][Full Text] [Related]
8. A new serologic staging system for large-cell lymphomas based on initial beta 2-microglobulin and lactate dehydrogenase levels.
Swan F; Velasquez WS; Tucker S; Redman JR; Rodriguez MA; McLaughlin P; Hagemeister FB; Cabanillas F
J Clin Oncol; 1989 Oct; 7(10):1518-27. PubMed ID: 2674337
[TBL] [Abstract][Full Text] [Related]
9. Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte.
Wendum D; Sebban C; Gaulard P; Coiffier B; Tilly H; Cazals D; Boehn A; Casasnovas RO; Bouabdallah R; Jaubert J; Ferrant A; Diebold J; de Mascarel A; Gisselbrecht C
J Clin Oncol; 1997 Apr; 15(4):1654-63. PubMed ID: 9193366
[TBL] [Abstract][Full Text] [Related]
10. Serum IL-6, IL-8, IL-10 and beta2-microglobulin in association with International Prognostic Index in diffuse large B cell lymphoma.
Duletić-Nacinović A; Stifter S; Marijić B; Lucin K; Valković T; Petranović D; Jonjić N
Tumori; 2008; 94(4):511-7. PubMed ID: 18822687
[TBL] [Abstract][Full Text] [Related]
11. Serum beta(2)-microglobulin and serum thymidine kinase are independent predictors of progression-free survival in chronic lymphocytic leukemia and immunocytoma.
Hallek M; Wanders L; Ostwald M; Busch R; Senekowitsch R; Stern S; Schick HD; Kuhn-Hallek I; Emmerich B
Leuk Lymphoma; 1996 Aug; 22(5-6):439-47. PubMed ID: 8882957
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the proliferative index as a prognostic factor in diffuse large cell lymphoma: correlation with the International Index.
Ansell SM; Kurtin PJ; Stenson M; Habermann TM; Greipp PR; Therneau TM; Witzig TE
Leuk Lymphoma; 1999 Aug; 34(5-6):529-37. PubMed ID: 10492076
[TBL] [Abstract][Full Text] [Related]
13. Beta-2 microglobulin and lactate dehydrogenase levels are useful prognostic markers in early stage primary gastric lymphoma.
Avilés A; Narváez BR
Clin Lab Haematol; 1998 Oct; 20(5):297-302. PubMed ID: 9807677
[TBL] [Abstract][Full Text] [Related]
14. Beta-2 microglobulin as a significant prognostic factor and a new risk model for patients with diffuse large B-cell lymphoma.
Kanemasa Y; Shimoyama T; Sasaki Y; Tamura M; Sawada T; Omuro Y; Hishima T; Maeda Y
Hematol Oncol; 2017 Dec; 35(4):440-446. PubMed ID: 27238634
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of serum beta 2 microglobulin in primary gastric lymphoma.
Avilés A; Díaz-Maqueo JC; Rodriguez L; García EL; Guzmán R; Talavera A
Hematol Oncol; 1991; 9(2):115-21. PubMed ID: 1869242
[TBL] [Abstract][Full Text] [Related]
16. Predictive model for prognosis in advanced diffuse histiocytic lymphoma.
Danieu L; Wong G; Koziner B; Clarkson B
Cancer Res; 1986 Oct; 46(10):5372-9. PubMed ID: 3530438
[TBL] [Abstract][Full Text] [Related]
17. The significance of bone marrow involvement in aggressive lymphomas: A retrospective comparison of clinical outcomes between peripheral T cell lymphoma and diffuse large B cell lymphoma in China.
Yi S; An G; Qi J; Zou D; Zhao Y; Zhang P; Chen H; Wang J; Qiu L
Acta Haematol; 2010; 124(4):239-44. PubMed ID: 21099213
[TBL] [Abstract][Full Text] [Related]
18. [Retrospective analysis of the clinical features and prognostic factors of 370 patients with advanced-stage diffuse large B-cell lymphoma].
Han Y; Qin Y; He XH; Yang JL; Liu P; Zhang CG; Zhou LQ; Zhou SY; Gui L; Song YW; Sun Y; Shi YK
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):456-461. PubMed ID: 29936773
[No Abstract] [Full Text] [Related]
19. A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.
Melchardt T; Troppan K; Weiss L; Hufnagl C; Neureiter D; Tränkenschuh W; Hopfinger G; Magnes T; Deutsch A; Neumeister P; Hackl H; Greil R; Pichler M; Egle A
Br J Haematol; 2015 Jan; 168(2):239-45. PubMed ID: 25236324
[TBL] [Abstract][Full Text] [Related]
20. Serum CA 125 as a prognostic factor in non-Hodgkin's lymphoma.
Bairey O; Blickstein D; Stark P; Prokocimer M; Nativ HM; Kirgner I; Shaklai M
Leuk Lymphoma; 2003 Oct; 44(10):1733-8. PubMed ID: 14692526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
